Search Videos and More
Phoenix Children’s Researcher Awarded $3 Million Grant to Develop New Therapy for Lung Diseases in Premature Babies
An internationally renowned research scientist at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine – Phoenix has been awarded a multimillion-dollar grant from the National Institutes of Health (NIH) to develop new treatment methods for lung disease in premature infants.Congenital Heart Disease: Helping Parents and Providers
Congenital heart disease is a common birth defect. Ericka Scheller McLaughlin, DO, pediatric and fetal cardiologist, discusses what parents can expect and how Phoenix Children’s can help.BPD: Progress Through Teamwork and the National BPD Collaborative
Bronchopulmonary dysplasia (BPD) is the most common respiratory complication of prematurity, affecting an estimated 10,000 to 15,000 babies in the U.S. annually - about 33 percent of babies born with a birthweight of less than 1,000 grams.Updates in Prenatal Radiographic Evaluation of Congenital Transverse Limb Deficiencies
Congenital transverse deficiencies are horizontal deficiencies of the long bones that occur with a reported incidence as high 0.38%.Decreasing Time Between Birth and BAS Improves Outcomes in Infants with d-TGA
Infants with dextro-transposition of the great arteries (d-TGA) are at high risk for hemodynamic compromise in the immediate postnatal period due to dependence on intracardiac mixing for oxygen delivery.Congenital Diaphragmatic Hernia: The Benefits of Teamwork
Pediatric surgeon Mark Molitor, MD, director of ECMO and Phoenix Children’s Congenital Diaphragmatic Hernia Clinic, explains diaphragmatic hernias and what makes the program that treats them at Phoenix Children’s so unique in Arizona and around the world.Phoenix Children's Building New NICU
Phoenix Children’s, one of the nation’s fastest-growing pediatric health systems, today announced the construction of a new 44,000-square-foot neonatal intensive care unit (NICU), slated to open next year at Phoenix Children’s Hospital — Thomas Campus.An International Consensus: Intracranial multimodal monitoring in neurocritical care
While intracranial multimodal monitoring (iMMM) is increasingly used in neurocritical care, a lack of standardization hinders its evidence-based development.Novel Risk Score to Guide Evaluation of Acute Hematogenous Osteomyelitis in Children
Claudia Yeung, MD et al., conducted a retrospective matched case-control study to identify independent predictors of acute hematogenous osteomyelitis (AHO) in children.Neuro-Sedative Use in the Inpatient Setting
Pharmacist Rhonda Kurz spoke on the variability in use of medications for BPD and variability of individual responses to medications.Super Resolution Fetal MRI
Super Resolution Fetal MRIs and their benefits including: enhanced visualization of fetal anatomy, potential for 3D and 4D reconstructions, improved diagnostic accuracy in complex congenital anomalies and highlighted the ongoing advancements and clinical impact of these techniques.4th Annual Current Perspectives in Bronchopulmonary Dysplasia 2024
In September 2024, leading experts and healthcare professionals explored the latest advancements in the understanding, diagnosis and treatment of bronchopulmonary dysplasia. Registration for the 2025 Symposium coming soon!